Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CLSK vs GSK✓SelectedUSD · GSKCLSK vs GSK performance historyLatest closeAs of-5.26%11/16
Stock and ETF performance explorer

CLSK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+59.9%
GSK return
+62.7%
Excess return
-2.8%
Maximum drawdown
-75.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.3%-0.1%-5.2%-5.3%
7D-8.8%-1.3%-7.5%-9.1%
30D-25.0%+2.7%-27.7%-24.3%
3M-47.9%+2.7%-50.6%-47.3%
6M-51.9%+3.3%-55.3%-51.4%
YTD-37.7%+6.5%-44.2%-36.5%
1Y-42.5%+10.7%-53.2%-41.3%
All+59.9%+62.7%-2.8%+43.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling